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Abstract
Vestibulodynia, the most common type of chronic vulvovaginal pain, impairs the psychological,
physical health of nearly 10% of women at some point in their lifetime. The aim of this
investigation was to establish reliable standardized methodologies for assessment of pain
sensitivity in vulvar mucosa and pelvic musculature. We enrolled 34 women with vestibulodynia
and 21 pain-free controls. The participants underwent a nuanced exam that consisted of palpation
of precisely located vulvar mucosal and pelvic muscle sites. These measurements remained highly
stable when participants were reexamined after two weeks, with high within-examiner correlation.
Vestibulodynia patients reported greater sensitivity than pain-free controls at the majority of
examination sites, particularly at mucosal sites on the lower vestibule. The pain threshold
measures at the lower mucosal sites were also associated with the participants’ self-reported pain
levels during intercourse. These mucosal pain threshold measurements were used to discriminate
between vestibulodynia cases and controls with high sensitivity and specificity. This data supports
the feasibility of contemporaneous assessment of vulvar mucosa and underlying musculature in
the pelvic region, offering the hope of a more precise case definition for vestibulodynia and
related disorders.
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Introduction
Vestibulodynia, the most common type of chronic vulvovaginal pain (vulvodynia), impairs
the physical, reproductive, and psychological health of nearly 1 in 10 women at some point
in their lifetime.7 Because little is known about the etiology and optimal management of this
disorder, most sufferers are left disillusioned.13 Historically, vestibulodynia has been viewed
as a localized disorder of the vulvar mucosa and surrounding region (specifically, underlying
musculature). However, over the past decade, a growing body of literature provides
evidence in support of vestibulodynia as an idiopathic pain disorder (akin to fibromyalgia
and temporomandibular pain disorder) with abnormalities in both peripheral and central
nervous system processes.2, 19
The clinical diagnostic criteria for vestibulodynia dates back to Friedrich’s case series of 86
patients published in 1987.5 He proposed the following three clinical criteria (known as
Friedrich criteria) for establishing the diagnosis of the elusive condition he called “Vulvar
Vestibulitis Syndrome”: 1) entry dyspareunia (painful intercourse), 2) tenderness to pressure
within the vestibule, and 3) physical findings limited to erythema without other obvious
pathology.5 Over the past decade, the body of literature on vestibulodynia has expanded.
However, revised criteria (based on elements of the history and an objective clinical exam)
beyond Friedrich’s initial description has not been formulated.
During clinical examination, the vulvar mucosal tissue is typically assessed by the
application of a cotton swab, but the reliability and reproducibility of the patient’s response
are generally poor. For example, intra-examiner correlations as high as 0.73 (upper
vestibule, fig 1) and as low as 0.38 (lower vestibule, fig 1) have been reported.9 Over the
past decade, many researchers have attempted to standardize the exam methodology.12
Pukall et al was the first to standardize the pressure application upon recognizing the
challenges of pain assessment in the vulvar region.10, 11 Their group developed 7 spring-
loaded syringes capable of applying a wide range of pressures (3 –1000 g). The examiner
sequentially applies higher pressure (using the preloaded syringe) until the tactile perception
or pain detection threshold is reached.10 However, the stability and reproducibility have not
been evaluated, and the anatomical locations of tested sites are not well characterized.
Unlike mucosa, the spectrum of normal and abnormal tenderness in the pelvic floor and its
constituent muscles (e.g. puborectalis muscle) has not been described. For evaluation of
pelvic muscle dysfunction, clinicians have utilized various subjective scales and surface
electromyography (sEMG) to assess voluntary control as a proxy for normal “tone” and
function. The usefulness and generalizability of various scales and sEMG are severely
limited by poor methodological design and lack of normative data.8, 16 Aside from these
techniques, there is limited data on the assessment of pressure pain sensitivity in pelvic
musculature using a mechanical algometer in pain-free women.17
Our overarching hypothesis is that vestibulodynia is a heterogeneous disorder and that
mucosal and muscle pain sensitivities can be used to identify distinct subgroups of patients.
The purpose of this study was three fold: 1) to develop instrumentation and methodology for
the objective assessment of vulvar mucosal and pelvic muscle sensitivities, 2) to establish a
standardized clinical approach for assessing pain sensitivity in vulvar mucosa and pelvic
musculature, and 3) to relate these measures to patients’ clinical pain reports. We began this
work by developing and validating tools capable of standardizing the force applied to the
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mucosa and muscle, enabling a wide spectrum of pain sensitivities to be quantitatively and
reproducibly assessed. We validated these instruments on women who experienced pain
since coital debut or attempted tampon use during adolescence.1 These women constitute the
most distressed subgroup of vestibulodynia patients.20
Materials and Methods
Participants
Thirty-four women with vestibulodynia and twenty-one pain free controls were recruited
through an institutional review board-approved protocol at the University of North Carolina,
Chapel Hill between March 2006 and August 2009. This study was nested within a larger
study (HD053631, PI DZolnoun) aimed at identifying and characterizing clinical phenotypes
of women with complaints of provoked pain in the mucosa of the vulvar vestibule.
A preliminary eligibility assessment of interested participants was conducted via a telephone
interview. A positive response to any of the following criteria lead to exclusion: 1) age<21
or age>45, 2) breastfeeding/pregnant, or menopausal, 3) significant medical conditions (e.g.
seizure disorder, diabetes, thyroid disorder), and 4) known diagnosis of co-morbid
urogenital pain conditions (e.g. non-menstrual daily pain localized to the pelvic region,
interstitial cystitis). Upon confirmation of general eligibility (the exclusions above did not
apply), potential subjects were queried regarding vulvovaginal symptoms. Women who
endorsed unprovoked pain/discomfort (such as burning, itching, knife like shooting pain)
with or without concomitant provoked pain upon contact were then excluded. Only women
without vulvo-vaginal complaints (potential controls) or isolated complaint of provoked pain
with intercourse and/or tampon use (potential cases) were scheduled for the clinical
eligibility assessment.
On the day of the clinical eligibility assessment, the research coordinator confirmed the
accuracy of the participant’s responses during the initial phone interview, followed by a
description of the study and informed consent. Participants were asked to complete a pain
questionnaire (the modified Gracely Pain Scale) after which they underwent a screening
gynecological exam. Using the Gracely Pain Scale, women rated the lowest, average and
maximal pain with intercourse on a scale of 0–100.6, 20 Modified versions of this
questionnaire are used by our research program for assessing pain in patients with other
idiopathic pain disorders (e.g. temporomandibular disorder and fibromyalgia) in addition to
vestibulodynia.
Vestibulodynia was diagnosed based on the subjective report of pain during intercourse (or
tampon use) and tenderness to touch upon palpation of the vestibule with a cotton swab
during the gynecological exam.10 This diagnosis was rendered only after the examining
clinician failed to identify any infectious or dermatological etiologies for the positive
responses. In the course of the screening examination, participants with suspected
dermatological disorders (e.g. lichen sclerosis, contact dermatitis), and vaginismus were
excluded (n=11 for the entire cohort).
Study design
Once eligibility as a case or control was established, participants underwent a nuanced
vulvar mucosal and pelvic muscle pain sensitivity assessment. For some subjects the exam
was repeated during the same session by a second examiner, or by one or two of the same
examiners in a separate session approximately two weeks later. The order of the second
examination was reversed such that second examiner in Session 1, was the first examiner in
Session 2, etc. Within each session, the second examination (when conducted) was
performed following a 5–10 min rest period.
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Our nuanced exam consisted of a standardized approach to stimulation of precisely located
vulvar mucosal and pelvic muscle sites (described below). This approach was adapted from
existing constructs on structured clinical exams in the orofacial region for which a
standardized methodology for mucocutaneous and muscle pain sensitivity assessment has
long been utilized.3 Six mucosal sites and three muscle sites were examined in a pre-
determined order. Pain perception thresholds were collected at each of the six mucosal sites.
Pain tolerance measures were not collected at the mucosal sites due to excessive sensitivity
of the vestibule in patients with vestibulodynia. Both pain perception threshold and pain
tolerance measures were collected from each of the three muscle sites. A prototypical
experimental session consisted of assessment of the vestibular mucosal pressure pain
perception threshold at each site, followed by the pelvic muscle pressure pain perception
threshold and pain tolerance testing at each site, which were conducted in a predetermined
order described below.
We first examined the upper vestibular sites (Fig. 1), which are least sensitive clinically, in
order to decrease the likelihood of obtaining lower threshold values if the more sensitive
lower vestibule were examined first.10, 12 Thus, the examination set yielded a minimum of
18 data points (3 at each of the 6 vestibular mucosa sites) in the course of the mucosal pain
perception assessment, and 9 data points (3 per each of the 3 muscle sites), in the course of
the muscle pain perception and tolerance testing each, respectively.
Our data include mucosal threshold measurements from 34 vestibulodynia patients and 21
pain-free controls, muscle threshold measurements from 33 vestibulodynia patients and 22
pain-free controls, and muscle tolerance measurements from 31 vestibulodynia patients and
20 pain-free controls. The data from the second visit of two subjects was excluded due to
calibration problems with the equipment on the day of these visits. Additionally, the
maximal mucosal threshold was set at 4 N. Mucosal measurements of greater than 4 N were
very rare, and often represented extreme outliers that could bias our analysis.
Mucosal Pressure Pain Detection Threshold Measurement
The 6 anatomical sites (3 on the upper vestibule and 3 on the lower vestibule) were
determined in reference to the conventional “clock face.” Using an imaginary clock, a total
of 12 equidistant sites on the vestibule can be described circumferentially, with positions 12
and 6 corresponding to the anterior and posterior position on the midline (in dorsal
lithotomy position). Thus, sites 10, 12, and 2 are located in the upper vestibule and sites 5, 6
and 7 are located in the lower vestibule (Fig. 1). Furthermore, we used anatomical
landmarks in order to standardize the location of these equidistant vestibular sites between
patients. Sites 2 and 10 correspond to the mid-positions on the vestibular mucosa located on
an imaginary line through the uretheral meatus and parallel to the horizontal plane. Sites 2
and 10 were examined in sequence, followed by Site 12, which was located equidistant from
the glan clitoris and the uretheral meatus (measured vertically). The lower three sites were
selected to be the mirror image of the upper three vestibular sites. Thus, 6 o’clock is the
most posterior position on the vestibule and equidistant from 5 o’clock position on the right
(subject’s left) and 7 o’clock position on the left (subject’s right). Following the examination
of the upper vestibular sites (2, 10, and 12), the lower vestibular sites were examined in the
following sequence: 5, 7, 6.
In collaboration with the biomedical engineering core at the Center for Neurosensory
Disorders at the University of North Carolina in Chapel Hill, we developed an algometer for
assessment of pressure pain sensitivity in the vestibule (Fig 2A) and the underlying pelvic
musculature (Fig 2B). For the former, we used a digital algometer (Wegner instruments®)
affixed to a disposable cotton swab and a custom-built computer interface for real time data
acquisition (Fig. 2A). Upon initiation of contact with the vestibular mucosa, the examiner(s)
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began application of pressure at an approximate rate of 1 N per second. Subjects were
instructed to click a computer mouse upon the first sensation of pain, at which point the
pressure was immediately terminated and automatically recorded as the “mucosal pressure
pain threshold.” Each mucosal site was examined three times with an inter-stimulus interval
(ISI) of 2 seconds. A verbal command via a computer interface announced the order of sites,
number of repetitions (3 per site), and the interval between the palpations of individual sites
and repetitions within each site. For example, a typical exam consisted of a verbal command
to start at site 2, and after obtaining three threshold values (with an ISI of 2 seconds) the
examiner was prompted to move to sites 10, 12, 5, 7, and 6 sequentially. Technical
specifications are described in detail at the following secure website: (https://www.unc.edu/
~ogmonbur/ea/wa-docs/wa-info1.html).
Muscle Pressure Pain Detection Threshold and Tolerance Measurements
Our pelvic muscle algometer (Fig 2B) uses a pressure sensor capable of measuring a wide
spectrum of force (<100g to >10kg or <1N to >98N) and allows direct and isolated palpation
of the levator muscles (specifically right and left puborectalis) and perineal muscle complex.
A computer program similar to the one described for the sensory assessment of the mucosa
allows real time data acquisition while standardizing the rate of application, inter-stimulus
and intra-stimulus intervals, and the order of examination. Technical specifications are
described in detail at the following secure website: (https://www.unc.edu/~ogmonbur/ea-
docs/ea-info1B.htm).
The pressure sensor is affixed to a plastic thimble that is worn over the examiner’s right
index finger (Fig. 2B). The exam is conducted transvaginally in accordance with
conventional clinical practice. However the manner in which the examination was
conducted (specifically subject/examiner interaction, verbal cue, and anatomical landmarks)
was standardized and scripted for the purposes of this protocol. The examination started
with the dorsal surface of the right index finger facing the subject’s right pubic rami. With a
bent index finger (approximately 30–60 degrees), the examiner palpates mid-pubic rami,
which is the bony landmark for identifying the mid-segment (belly) of puborectalis muscle.
After confirming the mid-position placement of the index finger, the examiner palpated the
puborectalis muscle, which was immediately adjacent/behind the pubic rami (<0.5 cm).
Subsequently, the examiner rotated the index finger downwards (approximate length of 1–
1.5 cm) parallel to the length of puborectalis, until the transition point/insertion to superficial
muscles (perineal muscle complex) was palpated. This was the point of pressure application
for the assessment of pain detection threshold and tolerance on the right and left puborectalis
muscle. Following the assessment of the right side, the examiner rotated his/her right hand
in order to palpate the left puborectalis as described above. The perineal muscle complex,
which is immediately underneath the 6 o’clock mucosal position, was palpated last. These
muscle sites are adjacent to the respective lower vestibular mucosal sites (5, 6, and 7)
Participants were instructed to click a mouse at the first sensation of pain (pain perception
threshold). However, the examiner terminated the pressure when she was no longer able to
apply additional force to reach the participant’s threshold. Both the amount of force and the
person who terminated the application (examiner versus subject) were recorded by the
computer. Following the completion of threshold testing, participants were given the option
to either proceed or opt out of the tolerance testing. Tolerance testing was performed
(47/51= 92% of participants) after a 5-minute rest period. Participants were instructed to
click the mouse when they were no longer able or willing to tolerate the pressure.
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Analysis of the mucosal/muscle algometer pain sensitivity measures presents special
challenges due to the nature of the data. At least three replicate measurements were collected
from each patient at each site, but for some patients, data was also collected on two different
visits and/or from two different examiners. Also, in some cases, the examiner was unable to
exert sufficient force to reach the subject’s threshold and terminated the measurement
procedure before the patient experienced pain, resulting in a measurement that is right-
censored. Nearly 50% of the muscle tolerance measures in the control group were
terminated by the examiner in this manner.
Failure to account for censoring mechanism has the potential to bias the results of any
comparison between cases and controls. Thus, to test the null hypothesis of no association
between these measurements and vestibulodynia case status, we fit a Cox proportional
hazards model to predict each algometer measurement based on a 0/1 dummy variable for
case status. We treated all measurements that were terminated by the examiner as censored.
To account for repeated measures for each patient, we treated the effect of each patient as a
Gaussian random effect (frailty). See Ripatti and Palmgren14 or Therneau et al.15 for a more
detailed description of this procedure. Each visit was also modeled as a random effect within
the random effect for the subjects. To test the null hypothesis of no association between a
given measure and vestibulodynia case status, we used a score test to test the null hypothesis
that the coefficient for the case status dummy variable was equal to 0. The effect size of case
status (and other covariates) was expressed as a hazard ratio, which is the relative likelihood
that a subject will terminate the procedure at any given force level compared to the baseline
risk group. In other words, if the hazard ratio for vestibulodynia case status is 2, then a given
patient with vestibulodynia is twice as likely as a pain-free participant to terminate the
procedure at any given force level.
Results
Demographics
Our cohort (n=55) consisted primarily of educated, white women in their late 20’s.
Demographic characteristics of women with vestibulodynia did not differ significantly from
the pain-free comparison group on: age (26.6 vs 27.7 yrs), ethnicity (80% vs 66.7% non-
hispanic white), education (77.1% vs 50% college educated), and marital status (42.9% vs
22.2% married)
Reproducibility
To establish reproducibility of the threshold measurement, the first measurement collected
for each subject at each site was compared to the third measurement collected by the same
experimenter at the same site (which was collected approximately 4 seconds later). All
subjects in the study (34 vestibulodynia patients and 21 healthy controls) were included in
this analysis. To assess reproducibility of the pain threshold over time, the results of the first
visit were compared to those of the second visit among subjects with two visits. Sixteen
women participated in two different visits, including 6 pain-free and 10 women with
vestibulodynia. Similarly, when two examiners collected measurements on the same subject
at the same visit, we compared the measurements of the two examiners to assess inter-
examiner reproducibility. There were 16 participants for whom we collected measurements
from two examiners at the same visit, including 4 pain-free and 12 women with
vestibulodynia. The mean difference (and associated standard errors) and the Pearson
correlation coefficients between each pair of measurements are shown in Table 1. The
correlation between the first and third measurement is very high for all three types of pain
threshold measurements at all sites; all such correlations except for one were 0.8 or greater.
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The mean differences between the first and third measurements are small (ranging from
0.018 N and 0.151 N) for the mucosal measurements. However, the third muscle
measurement (for both threshold and tolerance) was consistently lower than the first
measurement (the mean differences ranged between 0.55 N and 1.82 N), suggesting that
sensitivity increased with repetitive stimulation. The visit 1/visit 2 correlation is very high
for both mucosal and muscle measurements at all examination sites: The correlations ranged
from 0.547 to 0.871 for the mucosal data and from 0.748 to 0.85 for the muscle data. The
mean visit 1/visit 2 differences were modest for both mucosal and muscle measurements
(ranging between 0.008 N and 0.15 N for the mucosal measurements and 0.03 N and 1.68N
for the muscle measurements). The experimenter 1/experimenter 2 correlations were lower
(ranging from 0.107 to 0.577), and the mean experimenter 1/experimenter 2 differences
were larger (ranging from 0.071 N to 0.43 N for the mucosal measurements and 0.17 N to
3.9 N for the muscle measurements). This is not surprising given the challenges of
standardizing the actual conduct of the exam (see Discussion).
Group Differences in Mucosal and Muscle Pain Sensitivity Measures
Having established the reproducibility of the pain thresholds obtained by our instruments,
we evaluated their ability to discriminate between vestibulodynia patients (cases) and pain-
free controls. Figure 4 shows Kaplan-Meier plots of the set of mucosal detection thresholds
for pain-free controls and patients with vestibulodynia. There is a large difference in the
distribution of the mucosal perception thresholds between patients with vestibulodynia and
the pain-free comparison group. In all six of the measured mucosal sites, women with
vestibulodynia showed significantly lower pressure pain detection thresholds compared to
their pain-free counterparts. This was particularly robust at the lower vestibule,
corresponding to sites 5, 6, and 7.
Similarly, compared to pain-free participants, patients with vestibulodynia showed lower
pelvic muscle pressure pain threshold and tolerance measurements. Figure 5 shows the
corresponding Kaplan-Meier plots for the muscle threshold and tolerance measurements at
each of the three muscle sites.
To formally test the null hypothesis of no difference between the mucosal detection
thresholds between the two groups, we fit a Cox proportional hazards model to predict a
subject’s mucosal threshold based on an indicator variable for case status (see Methods). We
also fit a second model that adjusted for several covariates, namely a dummy variable for set
(reflecting which examiner went first and second), and an interaction term between set and
case status. The effects of other covariates were not significant so they were not included in
the final model. These results are summarized in Table 2.
The hazard ratio for vulvodynia case status was observed to be approximately 1.41 times the
hazard ratio for controls. This difference remained basically unchanged (1.29) after
adjustment for possible confounders. The hazard ratio varied from site to site. The ratio was
largest at sites 5, 6, and 7 and smallest at site 12 (Table 2). This suggests that sites 5, 6, and
7 may be the most informative sites for discriminating between women with vestibulodynia
and pain-free controls. Interestingly, when both examiners collected a set of measurements
at the same visit, pain-free participants had a lower hazard ratio during the second set of
measurements whereas vestibulodynia patients had a slightly higher hazard ratio. In other
words, women without pain were less likely to terminate the procedure at a given force level
during the second set than during the first set of measurements; no difference was observed
in vestibulodynia patients.
A similar approach tested the null hypothesis that the vestibulodynia patients and pain-free
comparison group had equal hazard ratios for the muscle measurements (both pain threshold
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and tolerance). Once again, we fit two Cox proportional hazards model to predict a subject’s
muscle threshold based on case status as vestibulodynia (Table 2). We also fit a second set
of Cox models that adjusted for covariates, but none of the coefficients of the covariates
were significantly different from 0, so these results are not reported in Table 2.
We observed a significant association between vestibulodynia case status and muscle
threshold measures when measurements from all three sites were combined (HR=2.9,
p=0.047). Examining each site separately, there is a significant association between
vestibulodynia case status and measurements at two of the three measured sites, namely sites
5 (HR=4.89, p=0.003) and 7 (HR=2.23, p<0.0001). There is a similar pattern of association
with respect to the muscle tolerance measures: the measurements were associated with
vestibulodynia case status across all three sites combined (HR=3.09, p=0.005), as well as at
sites 5 (HR=6.31, p=0.034) and 6 (HR=4.83, p=0.049) individually.
Clinical Relevance (Validity) of the Mucosal Pain Threshold as it relates to Subjective Pain
Reports
For the purpose of validating our instrument, the association between a patient’s self-
reported pain during intercourse and the patient’s mucosal and muscle measurements was
evaluated. Each participant was asked to rate her average pain during intercourse on a scale
from 0 to 100. To assess the association between mucosal threshold and intercourse-related
pain, we fit a Cox proportional hazards model to predict each woman’s mucosal threshold
based on her intercourse-related pain level, as described previously. Two models were fit:
one with only intercourse-related pain as a predictor, and one with intercourse-related pain
adjusted for examiner and measurement set. We observed a statistically significant
association between intercourse-related pain and mucosal threshold. The strength of this
association varied greatly from site to site. The association was strongest at sites 6
(p=0.009), 5 (p=0.004), and 7 (p= 0.028) and much weaker and non-significant at the upper
vestibular sites 2 (p=0.75), 10 (p=0.32), and 12 (p=0.38). For example, at mucosal site 6, a
respondent with a mild pain report (VAS=30) has a hazard ratio of 2.46 compared to a
respondent with no pain (VAS=0), and a respondent with a moderate pain report (VAS=60)
has a hazard ratio of 6.05 compared to a respondent with no pain. There was no statistically
significant association between intercourse-related pain and the muscle threshold or muscle
tolerance measurements.
Case-Control Classification
We have shown that vestibulodynia patients have lower average mucosal thresholds than
pain free controls. This raises the question of whether this result can be used to more
accurately diagnose patients with vestibulodynia in a clinical setting. We attempted to
answer this question by using a simple procedure to develop a classifier to discriminate
between vestibulodynia patients and pain-free controls. Since we previously observed that
mucosal measurements at sites 5, 6, and 7 are most strongly associated with intercourse-
related pain and case status, we built our classifier using only measurements from these
three sites. For each subject, we averaged her first three mucosal threshold measurements at
sites 5, 6, and 7. We then averaged these three averages to construct our final classifier. We
only considered measurements collected in the first measurement set of the first visit for
each patient. Also, we only considered measurements collected from examiner 1, since we
observed considerable variation in measurements collected by different examiners, and
examiner 1 collected more data than the other examiner.
The ROC curve for predicting case status based on this classifier is shown in Fig. 6. Note
that we can obtain both high sensitivity and specificity by choosing an appropriate cutoff for
discriminating between cases and controls. In particular, if we classify subjects with an
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average threshold force of less than 1 N as cases and subjects with an average threshold of
greater than 1 N as controls, then we obtain a sensitivity of 85.7% and a specificity of
82.4%. This suggests that our methodology has the potential to help diagnose patients with
provoked vestibulodynia.
Discussion
Provision for a reliable and valid system of pain assessment is a necessary first step toward
describing the prevalence, natural history and treatment outcomes in vestibulodynia. This is
particularly important in light of significant inter-individual variability of sensory
thresholds, quintessential to human perception in both diseased and non-diseased states.4 In
this study, we demonstrate that standardized methodologies based on psychophysical
approaches provide reliable indices of pelvic muscle and mucosal pressure pain sensitivity,
and that select indices relate to patients’ clinical pain reports.
The usefulness of examination methods requires both reliability (reproducibility) and
validity (accuracy) of the outcome measures. The reliability score is the conceptual sum of
four dynamic domains: intra-examiner and inter-examiner reliability, stability of
phenomenon being measured over time, and reliability of the participant’s pain report.3 To
date, limited work has been conducted on these domains with respect to the clinical
measurements of pelvic muscle and mucosal sensitivity. The methods we employed enabled
investigation of the joint and independent contribution of these domains (e.g. subject vs.
experimenter vs. time) on the reliability of measures of mucosal (threshold) and muscle
(threshold & tolerance) pressure pain sensitivity obtained by two examiners as much as two
weeks apart.
The measures were found to be temporally stable, as demonstrated by the high correlation
between values obtained from subsequent repetitions in the same visit and between values
obtained two weeks apart. The correlation between subsequent repetitions in a single exam
was excellent (r ≥ 0.8) indicating high reliability within the course of an exam. While the
between-visit correlations for the muscle and mucosal measurements were within
conventional norms (r ≥ 0.6),3 the mucosal correlations were not consistently over 0.6, being
as low as 0.54 at some sites (Table 1). However, upon closer inspection, the relatively lower
between-visit correlations (r=0.5–0.6) were consistently associated with upper vestibular
sites (Fig 1); whereas between-visit correlations for the lower three mucosal sites were on
the order of 0.8 and higher, similar in magnitude to those of the muscle measurements.
Meshab9 observed a similar discrepancy, which can be attributed to anatomical challenges.
Because of immediate proximity to the pubic bone, urethral meatus, and glan clitoris --- all
within a radius of 1 cm from the examined sites --- slight variation in the angle of cotton
swab application likely leads to variation in the measured threshold (Fig 1).
Inter-examiner reliability of pain measures
We observed low inter-examiner correlations, particularly for mucosal sites. Only one
mucosal site (6 o’clock) reached an acceptable inter-examiner correlation (r=0.577). The six
o’clock site was the only site tested for which the perpendicular application of pressure
using a cotton swab could be conducted under direct visualization with a high degree of
manual accuracy. On average the inter-examiner correlations for muscle were higher than
those for the mucosa; the highest correlation for muscle was seen at the 7 o’clock position.
This is attributed to the examiner’s ability to apply pressure in an anatomically congruent
manner (right handed examination of the patient’s right pelvic muscle). The examiner used
the right index finger to sequentially examine the right, left, and mid position. Because
muscle tolerance measures are primarily a reflection of examiner’s maximal force, lower
correlation between the two examiners was observed for pain tolerance than for pain
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detection thresholds. The lower inter-examiner reliability, particularly for mucosal
assessment, highlights the importance of training and calibrating the examiners.
Validity of pain measures
As eloquently discussed by Dworkin et al.3 “clinical measure may be extremely reliable or
repea=, but if a measure does not accurately portray the entity examined, then it provides no
useful information for diagnosis.” The construct of validity requires either 1) a “gold
standard,” in the form of an “accepted truth” based on empirical data, or 2) a validated
instrument that can be compared with the new approach. In our analysis, we used
participants’ self-reported pain during intercourse, a clinically meaningful construct, as a
proxy for a “gold standard”. Of the tested vestibular sites (six), only three lower vestibular
sites (5, 6, and 7) were associated with intercourse-related pain. Measures of muscle pain
sensitivity were not associated with participants’ self-reported pain during intercourse,
despite being associated with case status as described below.
Usefulness of pain measures in vestibulodynia identification
Compared to pain-free controls, vestibulodynia cases reported lower mucosal and muscle
thresholds, suggesting higher sensitivity. This was particularly evident for the lower
vestibular sites (5, 6, and 7), suggesting that these sites robustly discriminated cases from
controls. ROC analysis further demonstrated that an average threshold of less than 1N
provided a cut-off for discriminating between cases and controls with a sensitivity of 85.7%
and a specificity of 82.4%. This suggests that our methodology has the potential to help
diagnose patients with provoked vestibulodynia.
With respect to the muscle threshold measures, only two (sites 5 and 7) of the three tested
sites were significantly associated with case status. The group differences at sites 5 and 7
were notably smaller for muscle tolerance measures. In fact, the hazard ratio for muscle pain
tolerance at site 7 did not reach statistical significance (p= 0.09), despite being remarkably
robust (p<0.0001) for the muscle pain threshold measure.
Limitations
The extent to which increased sensitivity of the mucosa affected the pain threshold measured
for the pelvic musculature remains unclear. Because of the thinness of mucosa (<1 mm), our
methodology could have led to termination of pressure during the muscle examination due
to the experience of mucosal pain secondary to soft tissue traction. Because gentle pressure
(enough to indent the mucosa approximately 1 N) was sufficient for discriminating cases
from controls, the higher force used for the muscle examination in cases would be expected
to exceed the mucosal pain threshold of these patients.
Regardless of this possibility, our results suggest that transvaginal assessment of muscle
without irritating the overlying mucosa is possible. First, all of our participants with
vestibulodynia and mucosal pain thresholds of 1–4N completed the muscle threshold and
tolerance assessment where pressures as high as 30 N were sometimes delivered to reach the
pain threshold. Second, the 6 o’clock mucosal site was one of the most sensitive sites where
pressures as low as 1 N led to termination by subjects with vestibulodynia. However, an
association between case status and muscle pressure pain threshold (p=0.29) and tolerance
(p=0.06) at this position was not observed, suggesting that the two methodologies (mucosal
vs muscle) captured different, though arguably related constructs. Taken together, these
observations highlight the feasibility of transvaginal assessment of pelvic muscles without
irritating the overlying vulvar mucosa.
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We strived to standardize various facets of subject/examiner interaction and clinical
assessment. The research coordinator and the examiners followed a scripted protocol for
interacting with study participants. The coordinator explained the different aspects of the
exam and prompted the transition from one segment to another. However training and
calibration of examiners was quite limited in scope. In fact, it was during the conduct of the
present study that we identified elements of the exam that needed to be standardized. For
example, it was only after we began our study that we noticed that a slight deviation of the
wrist during mucosal assessment can change the intended location and angle of application
and that the anatomical distribution of the vulvar mucosa and muco-cutnaous junction
differs among subgroups of women.
The extent to which increased pain sensitivity of the pelvic musculature affected the pain
threshold measured at the vulvar mucosa remains unclear. The etiology of muscle
involvement in vestibulodynia is commonly viewed as reactive and secondary to overlying
mucosal sensitivity. However, we cannot compare the relative merit and directionality of the
relationship between muscle and mucosal sensitivity based on the magnitude of HR ratios
alone. Unlike mucosa which has a high fidelity input, the musculoskeletal input is
characterized by diffuse poorly localized low fidelity input.18 Therefore, it is plausible that
muscle may be the primary source of pain and functional aberration in some women, with
referral to the overlying mucosa. In other cases the mucosal input is primary with secondary
muscle involvement. Our study was not designed to address this question, but this
methodology will enable the design and implementation of future studies in order to
evaluate the directionality of this relationship (P01 NS045685, currently underway).
To our knowledge the work reported in this paper is the first research aimed at
operationalizing a standardize and validated clinical pain examination of the pelvic region.
Research into the pathophysiology of chronic pelvic pain in women is in its infancy and is in
urgent need of collaborative efforts among clinicians and scientists across a broad range of
expertise. Success will be dependent on standardized approaches, and we hope that they are
adopted and further developed by other investigators.
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This study describes performance characteristics of novel methodologies for assessing
pelvic muscle and mucosal sensitivity. These pain sensitivity measures were reproducible
and associated with subjective pain reports and vestibulodynia case status and represent
an important step toward a more precise case definition for vestibulodynia and related
disorders.
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Anatomical Location of The Tested Mucosal Sites
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Fig 2. Mucosal and Muscle Algometer
Real time data acquisition was conducted via a computer interface calibrated to A) Wegner
Digital algometer® custom fitted with a cotton swab for the purposes of mucosal sensitivity
assessment, B) Force Sensing Resistor (FSR) affixed on plastic thimble to examine pelvic
muscles
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Anatomical Location of The Tested Muscle Sites
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Fig 4. Kaplan-Meier Plots for Vulvar Mucosal Pressure Pain Detection Threshold
This figure shows the estimated “survival” probabilities (i.e. the probability of terminating
the exam prior to a given amount of force) for controls and vestibulodynia patients. The
termination pressure threshold (N) is shown on the x-axis, and the probability of surviving to
given threshold is shown on the y-axis. For example, the probability that a control will not
terminate the examination at site 2 prior to receiving 1 N of force is approximately 0.8.
Vestibulodynia patients were more likely than controls to terminate the force at a given
pressure at all 6 mucosal sites. The difference was more robust (as noted by a larger area
between the two curves) at lower vestibule sites.
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Fig 5. Kaplan-Meier Plots for Pelvic Muscle Pressure Pain Threshold and Tolerance
This figure shows the estimated “survival” probabilities (i.e. the probability of terminating
the exam prior to a given amount of force) for controls and vestibulodynia patients. The
termination pressure threshold/tolerance (N) is shown on the x-axis, and the probability of
surviving to given threshold is shown on the y-axis. For example, the probability that a
control will not terminate the muscle threshold examination at site 5 prior to receiving 10 N
of force is approximately 0.7. Compared to pain-free participants, patients with
vestibulodynia show lower pelvic muscle pressure pain threshold (upper panel) and
tolerance (lower panel) measurements.
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Fig 6. Receiver Operator Curve For Predicting Case Status
This figure shows the receiver operating characteristics (ROC) curve demonstrating the
predictive capability of the average of the three lower vestibular mucosal sites to predict
vestibulodynia case status. If we classify subjects with an average threshold of less than 1 N
as cases and subjects with an average threshold of greater than 1 N as controls, then we
obtain a sensitivity of 85.7% and a specificity of 82.4%.
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